PHARMACEUTICAL COMPOSITION
    11.
    发明申请
    PHARMACEUTICAL COMPOSITION 有权
    药物组合物

    公开(公告)号:US20100130576A1

    公开(公告)日:2010-05-27

    申请号:US12598044

    申请日:2008-04-16

    IPC分类号: A61K31/4168 A61P35/00

    摘要: To provide a pharmaceutical composition containing a 2-nitroimidazole derivative, which has high solubility in an aqueous carrier and high stability.The pharmaceutical composition is characterized by containing 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole and creatinine, and containing creatinine of 0.001 to 1 part by mass with respect to 1 part by mass of 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole.

    摘要翻译: 提供含有在水性载体中具有高溶解度和高稳定性的2-硝基咪唑衍生物的药物组合物。 该药物组合物的特征在于含有1-(1-羟甲基-2,3-二羟丙基)氧甲基-2-硝基咪唑和肌酸酐,相对于1质量份的1-(1 - 羟基甲基-2,3-二羟丙基)氧基甲基-2-硝基咪唑。

    PHARMACEUTICAL COMPOSITION
    12.
    发明申请
    PHARMACEUTICAL COMPOSITION 有权
    药物组合物

    公开(公告)号:US20100076042A1

    公开(公告)日:2010-03-25

    申请号:US12523067

    申请日:2008-01-17

    IPC分类号: A61K31/417 A61P35/00

    摘要: To provide a pharmaceutical composition which can enhance the storage stability of 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole without impairing the effect of the compound.The pharmaceutical composition includes 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole, which is represented by formula (1): and a compound having chelating ability.

    摘要翻译: 提供能够提高1-(1-羟甲基-2,3-二羟基丙氧基甲基)-2-硝基咪唑的保存稳定性的药物组合物,而不损害化合物的作用。 药物组合物包括由式(1)表示的1-(1-羟甲基-2,3-二羟基丙氧基甲基)-2-硝基咪唑:和具有螯合能力的化合物。

    ANTIFUNGAL COMPOSITION
    17.
    发明申请
    ANTIFUNGAL COMPOSITION 审中-公开
    抗真菌成分

    公开(公告)号:US20100173965A1

    公开(公告)日:2010-07-08

    申请号:US12676345

    申请日:2008-09-05

    IPC分类号: A01N43/50 A01P3/00

    摘要: Disclosed is a pharmaceutical composition for antifungal use, comprising: 1) one or more compounds selected from compounds represented by the general formula (1) below and physiologically acceptable salts thereof; 2) one or more compounds selected from polypropylene glycol, diesters of dibasic acids, triacetin, 2-ethyl-1,3-hexanediol, lauromacrogol, and polyoxyethylene-polyoxypropylene glycol; and 3) one or more compounds selected from glucono-δ-lactone, propylene glycol, glycerin, and lactic acid. General formula (1) (In the formula, X represents a halogen or hydrogen). wherein X represents a halogen or hydrogen.

    摘要翻译: 公开了一种用于抗真菌用途的药物组合物,包括:1)一种或多种选自下述通式(1)的化合物及其生理学可接受的盐; 2)一种或多种选自聚丙二醇,二元酸二酯,三醋精,2-乙基-1,3-己二醇,月桂醇和聚氧乙烯 - 聚氧丙烯二醇的化合物; 和3)一种或多种选自葡萄糖酸-δ-内酯,丙二醇,甘油和乳酸的化合物。 通式(1)(式中,X表示卤素或氢)。 其中X表示卤素或氢。